Zynerba Press Releases

6 Jan 16 Zynerba Pharmaceuticals Announces Positive Initial Results From ZYN002 CBD Gel Phase 1 Single Rising Dose Trial and Initiation of Phase 1 Multiple Rising Dose Trial

24 Nov 15 Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

16 Nov 15 Zynerba Pharmaceuticals Appoints Warren D. Cooper Lead Independent Director

11 Nov 15 Zynerba Pharmaceuticals Reports Third Quarter 2015 Financial Results and Operational Highlights

11 Nov 15 Zynerba Pharmaceuticals to Present at Jefferies Autumn 2015 Global Healthcare Conference

20 Oct 15 Zynerba Pharmaceuticals Initiates Phase 1 Clinical Trial for ZYN002 CBD Gel

7 Oct 15 Zynerba Pharmaceuticals to Present at BIO Investor Forum 2015

10 Aug 15 Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares

6 Aug 15 Zynerba Pharmaceuticals Builds Out Board of Directors

4 Aug 15 Zynerba Pharmaceuticals Announces Pricing of Its Initial Public Offering